AB0622 WHEN OSTEOPOROSIS, COELIAC DISEASE AND MULTIPLE MYELOMA CO-EXIST
نویسندگان
چکیده
Background: Secondary causes of bone loss are sometimes overlooked in patients who diagnosed as having osteoporosis. This is especially true if more than one risk factor for secondary osteoporosis present, with clinicians focusing on the common cause. Here we present a case caused by coeliac disease and multiple myeloma. Objectives: should be suspected very low mineral density those no obvious factors. Comprehensive examination investigations must done to look all because sometimes, seen our patient, you may find one. Methods: A 74 year old gentleman presented rheumatology clinic assessment He had been recently disease. DXA scan showed T score -3.5 at lumbar spine, -2.5 left hip Z -2.9. not sustained any fractures past. There was history corticosteroid exposure parental fracture or drank up 21 units alcohol week an ex-smoker. managing gluten-free diet. His testosterone vitamin D levels were normal. Serum electrophoresis, part workup, revealed diagnosis then developed back pain given his new myeloma, prompt carried out. skeletal survey T7 subsequent MRI impending cord compression, which treated successfully radiotherapy. underwent chemotherapy autologous stem cell transplantation OGD following post gluten rechallenge after established free biopsy shows evidence Interestingly, did only treat patient’s but also Results: Z-score useful indicator possible ?2.0 less below expected range age careful scrutiny underlying Coeliac gluten-sensitive enteropathy known cause It likely hyperparathyroidism from deficiency. Multiple myeloma aging adults resulting osteolytic and/or osteoporotic through increased resorption decreased formation pro-inflammatory cytokines. While malignancies, association rare, has described. Conclusion: highlights importance evaluating often, contributory factor. that could help identify would benefit thorough examination. References: [1]Sahin, Idris & Demir, Cengiz Alay, Murat Eminbeyli, Lokman. (2011). The Patient Presenting Renal Failure Due Myeloma Associated Celiac Disease: Case Report. UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi. 21. 10.4999/uhod.09087. [2]?pek, Belkiz Aksungar, Fehime Tiftikci, Arzu Coskun, Abdurrahman Serteser, Mustafa Unsal, Ibrahim. (2016). rare association: celiac asymptomatic young patient. Turkish Journal Biochemistry. 41. 10.1515/tjb-2016-0053. [3]Swaminathan K, Flynn R, Garton M, Paterson C, Leese G. Search osteoporosis: scores predictors? Postgrad Med J. 2009 Jan;85(999):38-9. doi: 10.1136/pgmj.2007.065748. PMID: 19240287. Disclosure Interests: None declared.
منابع مشابه
Osteoporosis in treated adult coeliac disease.
Forty five women and 10 men with coeliac disease diagnosed in adult life, who were already on a gluten free diet, had serial bone mineral density measurements at the lumbar spine and femoral neck over 12 months. Osteoporosis, defined as a bone mineral density (BMD) < or = 2 SD below the normal peak bone mass was found in 50% of male and 47% of female coeliac patients. Patients with a BMD < or =...
متن کاملMULTIPLE MYELOMA Myeloma bone disease
Bone destruction is a hallmark of multiple myeloma, and recent studies demonstrated a strong interdependence between tumor progression and bone resorption. Increased bone resorption as a major characteristic of multiple myeloma is caused by osteoclast activation and osteoblast inhibition (uncoupling). Myeloma cells alter the local regulation of bone metabolism by increasing the receptor activat...
متن کاملMultiple Myeloma Update
This literature review presents the most recent developments in the management of multiple myeloma, which is characterized by the presence of abnormal plasma cells (myeloma cells) that accumulate into the bone marrow. Aspects related to pathophysiology, clinical manifestations, laboratory, study and treatment are described. These pieces of information are necessary to accomplish a better ...
متن کاملTreatment of Multiple Myeloma
Les traitements classiques de myelome multiple et les schemas differents proposes ont ete mis en revue. La poly chimiotherapie de la maladie avec une com-binaison de cyclophosphamide, B.C.N.U. Alkeran, Perdnisone et Vincristine a donnee une meilleur Resultat ceci surtout dans les formes graves et rapidement progressive de la maladie. D'autres sehemas therapeutiques sont en cours.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of the Rheumatic Diseases
سال: 2021
ISSN: ['1468-2060', '0003-4967']
DOI: https://doi.org/10.1136/annrheumdis-2021-eular.3594